Lymphatic drug delivery: Therapy, imaging and nanotechnology

Advanced Drug Delivery Reviews

Volumn 63, Issue 10-11, 2011, Pages 865-866

  Cohen, Mark S ^a   Forrest, M Laird ^b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOMATERIAL; DENDRIMER; DENDRITIC CELL VACCINE; DRUG CARRIER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EXCIPIENT; FLUORESCENT DYE; GROWTH FACTOR; IMMUNOLOGICAL ADJUVANT; LIPOSOME; NANOCARRIER; NANOPARTICLE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; PHOSPHORYL LIPID A; POLYGLACTIN; QUANTUM DOT; RADIOISOTOPE; SOLID LIPID NANOPARTICLE; TRASTUZUMAB; VACCINE; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

CANCER CELL; CANCER RECURRENCE; CANCER STAGING; CELL INTERACTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG PENETRATION; DRUG RESEARCH; DRUG SAFETY; DRUG TRANSPORT; ECHOGRAPHY; EDITORIAL; ENCAPSULATION; FIRST PASS EFFECT; FLUORESCENCE ANALYSIS; FLUORESCENCE IMAGING; HUMAN; IMMUNE RESPONSE; INTESTINE LYMPH; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPH VESSEL ENDOTHELIUM; LYMPHATIC SYSTEM; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RESEARCH; METASTASIS POTENTIAL; NANOTECHNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY;

DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; LYMPHATIC SYSTEM; NANOPARTICLES; NANOTECHNOLOGY;

EID: 80052175364     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2011.05.013     Document Type: Editorial

References (0)